NYSE:A - Agilent Technologies Stock Price, Price Target & More

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies declared a quarterly dividend on Wednesday, May 16th. Stockholders of record on Tuesday, July 3rd will be given a dividend of $0.149 per share on Wednesday, July 25th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date is Monday, July 2nd. View Agilent Technologies' Dividend History.

Agilent Technologies Inc (NYSE:A) issued its quarterly earnings data on Monday, May, 14th. The medical research company reported $0.65 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.64 by $0.01. The medical research company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The company's revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.58 earnings per share. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Agilent Technologies.

Agilent Technologies updated its FY18 earnings guidance on Monday, May, 14th. The company provided EPS guidance of $2.63-2.67 for the period, compared to the Thomson Reuters consensus estimate of $2.70. The company issued revenue guidance of $4.85-4.87 billion, compared to the consensus revenue estimate of $4.92 billion.Agilent Technologies also updated its Q3 guidance to $0.61-0.63 EPS.

11 Wall Street analysts have issued 12-month price targets for Agilent Technologies' stock. Their forecasts range from $66.00 to $91.00. On average, they anticipate Agilent Technologies' share price to reach $73.9091 in the next twelve months. This suggests a possible upside of 15.8% from the stock's current price. View Analyst Ratings for Agilent Technologies.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), PerkinElmer (PKI), Bio-Rad Laboratories, Inc. Class B (BIO.B), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

News coverage about A stock has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Agilent Technologies earned a daily sentiment score of 0.24 on Accern's scale. They also assigned news stories about the medical research company an impact score of 46.73 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Agilent Technologies' stock is owned by a number of of institutional and retail investors. Top institutional investors include Calamos Advisors LLC (0.29%), Cambiar Investors LLC (0.17%), Factory Mutual Insurance Co. (0.14%), Bank of Montreal Can (0.07%), Retirement Systems of Alabama (0.05%) and Nisa Investment Advisors LLC (0.03%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Bank of Montreal Can, Fred Alger Management Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, TIAA FSB, Clinton Group Inc., State of Alaska Department of Revenue and Hartford Investment Management Co.. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was bought by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Factory Mutual Insurance Co., Verde Servicos Internacionais S.A., Xact Kapitalforvaltning AB, Fjarde AP Fonden Fourth Swedish National Pension Fund, IFM Investors Pty Ltd, Pwmco LLC and Calamos Wealth Management LLC. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $63.85.

Agilent Technologies has a market capitalization of $20.43 billion and generates $4.47 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.36 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]